G01N33/57426 - page 2 - CPC Classification Index

#301

20170313783

2017-11-02

Antibodies that specifically bind to TIM3

#302

20170307619

2017-10-26

MARKERS OF POOR PROGNOSIS ACUTE MYELOID LEUKEMIAS (AMLs) AND USES THEREOF

#303

20170306416

2017-10-26

Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof

#304

20170306410

2017-10-26

BCR-ABL1 splice variants and uses thereof

#305

20170306043

2017-10-26

Monoclonal antibody which specifically recognizes B cell lymphoma and use thereof

#306

20170304251

2017-10-26

AVOCADO-DERIVED LIPIDS FOR USE IN TREATING LEUKEMIA

#307

20170298441

2017-10-19

USE OF CLONAL EVOLUTION ANALYSIS FOR IBRUTINIB RESISTANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

#308

20170298132

2017-10-19

Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma

#309

20170291944

2017-10-12

JAM-C antibodies and methods for treatment of cancer

#310

20170285027

2017-10-05

METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT

#311

20170281665

2017-10-05

Methods of treating breast cancer that overexpress AKT kinase

#312

20170260270

2017-09-14

Anti CD84 antibodies, compositions comprising same and uses thereof

#313

20170252364

2017-09-07

COMPOSITIONS FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA AND METHODS OF USE THEREOF

#314

20170248604

2017-08-31

METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT

#315

20170227544

2017-08-10

METHODS FOR PERSONALIZING PATIENT CANCER THERAPY WITH AN MDM2 ANTAGONIST

#316

20170226227

2017-08-10

Treatment of Leukemias and Chronic Myeloproliferative Diseases with Antibodies to EphA3

#317

20170219589

2017-08-03

SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS

#318

20170219588

2017-08-03

METHOD OF SCREENING OF COMPOUNDS USING MEMBRANE STIM1

#319

20170218338

2017-08-03

Selective oxidation of 5-methylcytosine by TET-family proteins

#320

20170216337

2017-08-03

Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof

#321

20170216288

2017-08-03

Immunopotentiator potentiating tumor immunity or infection immunity

#322

20170199193

2017-07-13

Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies

#323

20170198048

2017-07-13

Method of treatment for leukemia using an anti-IL1RAP antibody

#324

20170191119

2017-07-06

Selective oxidation of 5-methylcytosine by TET-family proteins

#325

20170184600

2017-06-29

METHODS FOR DIAGNOSIS AND PROGNOSIS OF CANCER

#326

20170184598

2017-06-29

Diagnostic of chronic myelomonocytic leukemia (CMML) by flow cytometry

#327

20170184597

2017-06-29

METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT

#328

20170183741

2017-06-29

Treating chronic myelogenous leukemia (CML)

#329

20170174734

2017-06-22

DR6 Receptor Mediates the Leukemia Differentiation Activity of Angiocidin: A Potent Anti-Tumor Peptide

#330

20170173021

2017-06-22

Method and kits for identifying of CDK9 inhibitors for the treatment of cancer

#331

20170146538

2017-05-25

PRL-3 AS A BIOMARKER FOR THE PROGNOSIS OF CANCER AND A TARGET FOR THERAPY

#332

20170145484

2017-05-25

Selective oxidation of 5-methylcytosine by TET-family proteins

#333

20170143735

2017-05-25

Methods for treating, diagnosing and prognosing a haematological malignancy

#334

20170138958

2017-05-18

METHOD FOR MEASURING ANTI-WT1 ANTIBODY

#335

20170138948

2017-05-18

Differential cerebrospinal fluid reactivity to PFDN5-alpha for detection of B-cell acute lymphoblastic leukemia

#336

20170131281

2017-05-11

Method and kit for detection of deltanoid-resistant leukemia cells and antibody for use therein

#337

20170122947

2017-05-04

Risk-stratification of B-precursor acute lymphoblastic leukemia patients

#338

20170114408

2017-04-27

Diagnosis of hematologic diseases

#339

20170102389

2017-04-13

NEW BIOMARKER FOR OUTCOME IN AML PATIENTS

#340

20170100462

2017-04-13

Genomic instability markers in Fanconi anemia

#341

20170080102

2017-03-23

METHODS FOR CHARACTERIZING AND TREATING ACUTE MYELOID LEUKEMIA

#342

20170074883

2017-03-16

Identification of novel diagnostics and therapeutics by modulating RhoH

#343

20170073762

2017-03-16

Method for predicting the responsiveness a patient to a treatment with an anti-CD20 antibody

#344

20170066827

2017-03-09

CHIMERIC ANTIGEN RECEPTOR

#345

20170065628

2017-03-09

Inhibitors of human EZH2, and methods of use thereof

#346

20170051061

2017-02-23

Anti-vista antibodies and fragments

#347

20170045517

2017-02-16

Method for predicting prognosis of acute myeloid leukemia relapse

#348

20170038387

2017-02-09

METHODS FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO IMMUNOMODULATORY THERAPIES

#349

20170035795

2017-02-09

METHODS AND REAGENTS FOR THE DIAGNOSIS AND TREATMENT OF ACUTE LEUKEMIA

#350

20170029899

2017-02-02

Natural-killer/T-cell lymphoma (NKTCL) susceptibility prediction, diagnosis and therapy

#351

20170016902

2017-01-19

METHOD OF TREATING AND REDUCING THE RISK OF ACUTE MYELOGENOUS LEUKEMIA

#352

20170007608

2017-01-12

ACTIVATORS OF PYRUVATE KINASE M2 AND METHODS OF TREATING DISEASE

#353

20160377627

2016-12-29

Methods apparatuses and systems for detecting and quantifying phosphoproteins

#354

20160376333

2016-12-29

Polypeptides to inhibit epstein barr viral protein BHRF1 and B cell lymphoma family proteins

#355

20160370372

2016-12-22

Personalized myeloma detection

#356

20160368943

2016-12-22

Substituted purine compounds

#357

20160363595

2016-12-15

Method for treatment of blood tumor using anti-TIM-3 antibody

#358

20160361391

2016-12-15

REDUCTION OF TRAF1 LEVELS COMBINED WITH NUTRIENT STRESS FOR TREATING LYMPHOCYTE-RELATED CANCERS

#359

20160361309

2016-12-15

METHODS OF TREATING CANCER PATIENTS RESPONDING TO EZH2 INHIBITOR GSK126

#360

20160356778

2016-12-08

Methods for determining drug efficacy for treatment of cancer ration of cereblon associated proteins

#361

20160349261

2016-12-01

G-protein coupled receptor-associated diagnostics and therapeutics for B-cell chronic lymphocytic leukemia

#362

20160319370

2016-11-03

TET2 as a diagnostic and prognostic marker in hematopoietic neoplasms

#363

20160319005

2016-11-03

Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor

#364

20160313300

2016-10-27

METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS

#365

20160311920

2016-10-27

Diagnosis and treatment of cancer using anti-ITM2A antibody

#366

20160305945

2016-10-20

Leukemic stem cell markers

#367

20160304973

2016-10-20

CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia

#368

20160304618

2016-10-20

ANTIBODIES FOR DIAGNOSIS OF ACUTE MYELOID LEUKEMIA

#369

20160303109

2016-10-20

Crenolanib for treating FLT3 mutated proliferative disorders

#370

20160303101

2016-10-20

Predicting response to alvocidib by mitochondrial profiling

#371

20160291023

2016-10-06

Antibody and aptamer ensemble for cell isolation and enrichment

#372

20160280792

2016-09-29

Polynucleotide encoding antibody to human IL-3 receptor alpha chain

#373

20160280694

2016-09-29

5-amino-quinoline-8-carboxamide derivatives as 5-HT4 receptor agonists

#374

20160258931

2016-09-08

Methods for assessing cell viability or predicting cell response to a treatment using cell movement

#375

20160251723

2016-09-01

Mutant calreticulin for the diagnosis of myeloid malignancies

#376

20160251696

2016-09-01

Methods of diagnosing and treating B cell acute lymphoblastic leukemia

#377

20160250163

2016-09-01

Compounds suitable for the treatment of myeloproliferative neoplasms as well as methods for the diagnosis/prognosis of myeloproliferative neoplasms

#378

20160237118

2016-08-18

Leukemia stem cell targeting ligands and methods of use

#379

20160223554

2016-08-04

METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT

#380

20160175437

2016-06-23

PROTEIN

#381

20160169901

2016-06-16

METHODS FOR DIAGNOSIS OF CUTANEOUS T-CELL LYMPHOMA

#382

20160153998

2016-06-02

BIOMARKERS FOR PREDICTING THE SENSITIVITY OF CELLS TO IMMUNOMODULATORY COMPOUNDS DURING TREATMENT OF NON-HODGKIN'S LYMPHOMA

#383

20160152724

2016-06-02

Fusion protein to target and treat acute myeloid leukemia cells

#384

20160146821

2016-05-26

Detection of acute myeloid leukaemia (AML) leukaemic stem cells (LSC)

#385

20160131655

2016-05-12

BCMA-BASED STRATIFICATION AND THERAPY FOR MULTIPLE MYELOMA PATIENTS

#386

20160131654

2016-05-12

Diagnostic, prognostic, and monitoring methods for multiple myeloma, chronic lymphocytic leukemia, and B-cell non-hodgkin lymphoma

#387

20160130659

2016-05-12

COMPOSITIONS AND METHODS FOR TREATING CANCER

#388

20160130346

2016-05-12

KIR3DL2 IS A BIOMARKER AND A THERAPEUTIC TARGET USEFUL FOR RESPECTIVELY PREVENTING AND TREATING A SUBSET OF CUTANEOUS AND NON-CUTANEOUS PERIPHERAL T-CELL LYMPHOMAS

#389

20160123985

2016-05-05

Hematopoietic cell phenotyping using circulating cell-free markers

#390

20160097770

2016-04-07

METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT

#391

20160077096

2016-03-17

Treating patients based on immune subtypes

#392

20160075787

2016-03-17

Anti-CLL-1 antibodies and immunoconjugates

#393

20160069900

2016-03-10

Immunoassay for soluble PD-L1

#394

20160068610

2016-03-10

GLUTAMATE DEHYDROGENASE IN IDH1- AND IDH2-MUTATED CANCERS

#395

20160060709

2016-03-03

Biomarkers for acute myeloid leukemia

#396

20160060342

2016-03-03

Markers of acute myeloid leukemia stem cells

#397

20160041184

2016-02-11

IDENTIFICATION AND MONITORING OF MONOCLONAL IMMUNOGLOBULINS BY MOLECULAR MASS

#398

20160025746

2016-01-28

Methods of screening compounds that can modulate NR2F6 by displacement of a reference ligand

#399

20160025731

2016-01-28

Polymer backbone element tags

#400

20160022684

2016-01-28

BET INHIBITOR AND BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS

#401

20160017429

2016-01-21

METHOD FOR PROGNOSING THE SURVIVAL OF PATIENTS SUFFERING FROM CHRONIC MYELOMONOCYTIC LEUKAEMIA

#402

20160011200

2016-01-14

Replication protein

#403

20160002345

2016-01-07

A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA

#404

20150368726

2015-12-24

Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof

#405

20150368300

2015-12-24

Compositions and methods relating to hindering DOT1L recruitment by MLL-fusion proteins

#406

20150359799

2015-12-17

Methods of treating, preventing and diagnosing leukemia and other blood diseases and disorders

#407

20150354006

2015-12-10

MARKERS FOR ACUTE LYMPHOBLASTIC LEUKEMIA

#408

20150344972

2015-12-03

Compositions comprising soluble CD84 or anti-CD84 antibodies and methods for diagnosing and treating B-CLL

#409

20150344971

2015-12-03

Method for diagnosis, prognosis and determination of treatment for cutaneous T-cell lymphoma

#410

20150344953

2015-12-03

RNF41 as a biomarker predicting response to lenalidomide in non-del(5q) MDS

#411

20150338409

2015-11-26

Markers for abnormal cells

#412

20150329643

2015-11-19

IDENTIFICATION AND USE OF NEW TUMOR-PROMOTING GENE IN HEMATOLOGICAL MALIGNANCIES

#413

20150307612

2015-10-29

Biological materials related to c-Met

#414

20150301053

2015-10-22

SURROGATE FUNCTIONAL DIAGNOSTICS TEST FOR CANCER

#415

20150299801

2015-10-22

Techniques for Treating Acute Lymphoblastic Leukemia (ALL)

#416

20150285805

2015-10-08

BIOMARKERS OF MULTIPLE MYELOMA DEVELOPMENT AND PROGRESSION

#417

20150276745

2015-10-01

METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT

#418

20150267261

2015-09-24

Phospholipase C gamma 2 and resistance associated mutations

#419

20150259428

2015-09-17

CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same

#420

20150252430

2015-09-10

Methods for the identification, assessment, and treatment of patients with cancer therapy

#421

20150246971

2015-09-03

JAM-C antibodies and methods for treatment of cancer

#422

20150238490

2015-08-27

BIOMARKERS FOR PREDICTING RESPONSE OF DLBCL TO TREATMENT WITH IBRUTINIB

#423

20150231240

2015-08-20

ANTI-C16ORF54 ANTIBODIES AND METHODS OF USE THEREOF

#424

20150218287

2015-08-06

TUMOR SELECTIVE ANTIBODIES SPECIFIC TO ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR PROTEIN

#425

20150204876

2015-07-23

Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients

#426

20150184245

2015-07-02

Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof

#427

20150184222

2015-07-02

Diagnostic and prognostic assays based on circulating tyrosine kinase activity

#428

20150141362

2015-05-21

Inhibitors of human EZH2, and methods of use thereof

#429

20150125453

2015-05-07

Monoclonal canine CD20 antibodies and methods of use

#430

20150119421

2015-04-30

Method of inhibiting FLT3 kinase

#431

20150118247

2015-04-30

METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

#432

20150110714

2015-04-23

Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand

#433

20150105283

2015-04-16

MULTIPLEXED DIAGNOSIS METHOD FOR CLASSICAL HODGKIN LYMPHOMA

#434

20150094217

2015-04-02

TEST FOR DIAGNOSING RESISTANCE TO AZACITIDINE

#435

20150087006

2015-03-26

Cellular cis-co-culture systems for analysis

#436

20150086575

2015-03-26

B CELL SURFACE REACTIVE ANTIBODIES

#437

20150086574

2015-03-26

Antibodies that specifically bind to TIM3

#438

20150080255

2015-03-19

MPL mutations in JAK2 V617F negative patients with myeloproliferative disease

#439

20150079091

2015-03-19

Mutant calreticulin for the diagnosis of myeloid malignancies

#440

20150072357

2015-03-12

Cholesteryl Succinyl Silane Bound Proteins and Methods For Producing and Using the Same

#441

20150064801

2015-03-05

Method for producing reagent for antibody detection and use thereof

#442

20150051263

2015-02-19

Identification of a JAK2 mutation in polycythemia vera

#443

20150023991

2015-01-22

Means and methods for treating or diagnosing IDH1 R132H mutant-positive cancers

#444

20150018225

2015-01-15

CELL ADHESION INHIBITOR, CELL PROLIFERATION INHIBITOR, AND METHOD AND KIT FOR EXAMINING CANCER

#445

20150017119

2015-01-15

Methods for diagnosis, prognosis and methods of treatment

#446

20150005361

2015-01-01

Induced pluripotent stem cell model of chronic myeloid leukemia revealed olfactomedin 4 as a novel therapeutic target in leukemia stem cells

#447

20150004613

2015-01-01

METHODS FOR TREATING HEMATOPOIETIC MALIGNANCIES

#448

20140364481

2014-12-11

RNA chimeras in human leukemia and lymphoma

#449

20140348840

2014-11-27

Method of treating and reducing the risk of acute myelogenous leukemia

#450

20140342920

2014-11-20

Biomarkers for non-hodgkin lymphomas and uses thereof

#451

20140342374

2014-11-20

Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof

#452

20140341903

2014-11-20

Biological materials related to c-Met

#453

20140335103

2014-11-13

Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof

#454

20140328843

2014-11-06

Combination of FcγRIIB-specific antibodies and CD20-specific antibodies and methods of use thereof

#455

20140316125

2014-10-23

Truncated CD20 protein, deltaCD20

#456

20140308669

2014-10-16

METHODS FOR OBTAINING SINGLE CELLS AND APPLICATIONS OF SINGLE CELL OMICS

#457

20140308301

2014-10-16

CD44 MONOCLONAL ANTIBODY FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER HEMATOLOGICAL MALIGNANCIES

#458

20140302059

2014-10-09

Compositions and methods for cancer and cancer stem cell detection and elimination

#459

20140296095

2014-10-02

Spatially Selective Release of Aptamer-Captured Cells by Temperature Mediation

#460

20140288087

2014-09-25

Methods for sensitizing a quiescent cancer stem cell to a BCR-ABL inhibitor

#461

20140275081

2014-09-18

Inhibitors of human EZH2, and methods of use thereof

#462

20140274788

2014-09-18

LEUKEMIA STEM CELL MARKERS

#463

20140255431

2014-09-11

Markers of acute myeloid leukemia stem cells

#464

20140248633

2014-09-04

Leukemia stem cell targeting ligands and methods of use

#465

20140242602

2014-08-28

Uses of labeled HSP90 inhibitors

#466

20140227799

2014-08-14

Method for measuring anti-WT1 antibody

#467

20140220562

2014-08-07

Method of predicting responsiveness of B cell lineage malignancies to active immunotherapy

#468

20140213470

2014-07-31

METHODS FOR USE WITH BAFF ANTAGONISTS

#469

20140199238

2014-07-17

Targeting of bone marrow neovasculature

#470

20140193433

2014-07-10

BCMA-BASED STRATIFICATION AND THERAPY FOR MULTIPLE MYELOMA PATIENTS

#471

20140193420

2014-07-10

DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-ITM2A ANTIBODY

#472

20140193333

2014-07-10

Therapeutic and diagnostic target

#473

20140162282

2014-06-12

Methods for determining drug efficacy using cereblon-associated proteins

#474

20140148354

2014-05-29

Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia

#475

20140147451

2014-05-29

Compositions comprising soluble CD84 or anti-CD84 antibodies and methods for diagnosing and treating B-CLL

#476

20140141427

2014-05-22

BCR-ABL1 splice variants and uses thereof

#477

20140127711

2014-05-08

Method and system for detecting lymphosarcoma in cats using biomarkers

#478

20140066480

2014-03-06

Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs

#479

20140005250

2014-01-02

Compositions and methods for increasing drug efficacy in cancer

#480

20130337471

2013-12-19

CELL IDENTIFICATION WITH NANOPARTICLES, COMPOSITIONS AND METHODS RELATED THERETO

#481

20130295107

2013-11-07

Antibody to human IL-3 receptor alpha chain

#482

20130273077

2013-10-17

Antibodies to NTB-A

#483

20130267579

2013-10-10

Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias

#484

20130266962

2013-10-10

Means and methods for diagnosing cancer using an antibody which specifically binds to BRAF V600E

#485

20130266510

2013-10-10

Compositions and methods for treatment of drug resistant multiple myeloma

#486

20130230521

2013-09-05

Tumor-targeting monoclonal antibodies to FZD10 and uses thereof

#487

20130225425

2013-08-29

Modulation of NR2F6 and methods and uses thereof

#488

20130212715

2013-08-15

Stat5b transgenic mice and methods of use thereof

#489

20130203831

2013-08-08

Non peptidic 14-3-3 inhibitors and the use thereof

#490

20130202624

2013-08-08

Human B1 cells and uses thereof

#491

20130189683

2013-07-25

Identification of a JAK2 mutation involved in vaquez polyglobulia

#492

20130189675

2013-07-25

Assay to capture and detect circulating multiple myeloma cells from blood

#493

20130177936

2013-07-11

Method of cancer diagnosis using the analysis of isotopes

#494

20130158236

2013-06-20

Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

#495

20130137595

2013-05-30

Biomarkers for lymphoma

#496

20130131139

2013-05-23

ROR1 AS A GENE TARGET IN ACUTE LYMPHOBLASTIC LEUKEMIA

#497

20130129736

2013-05-23

ASPP2 splicing variant

#498

20130079424

2013-03-28

Methods for identifying leukemia stem cells and distinguishing them from normal hematopietic stem cells in patients with acute myeloid leukemia: uses in diagnosis, treatment, and research

#499

20130065887

2013-03-14

Methods for identifying and validating selective anti-cancer stem cell agents

#500

20130059746

2013-03-07

GENE EXPRESSION PROFILING OF CYTOGENETIC ABNORMALITIES

#501

20130058863

2013-03-07

4-Protein Biomarker Panel for the Diagnosis of Lymphoma from Biospecimen

#502

20130053262

2013-02-28

MPL mutations in JAK2 V617F negative patients with myeloproliferative disease

#503

20130052206

2013-02-28

Prognostic marker for cryoglobulinemic vasculitis and B cell malignancies in HCV infected patients

#504

20130040906

2013-02-14

Inhibitors of human EZH2, and methods of use thereof

#505

20130035253

2013-02-07

METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT

#506

20130034862

2013-02-07

Methods for Diagnosis, Prognosis and Methods of Treatment

#507

20130029363

2013-01-31

Method for diagnosing malignant tumor

#508

20130022623

2013-01-24

Antibodies that specifically bind to TIM3

#509

20130013334

2013-01-10

Methods for the identification, assessment, and treatment of patients with cancer therapy

#510

20130005678

2013-01-03

Methods and Compositions for Treating or Ameliorating Cancer Using Gemcitabine-5'-Elaidate

#511

20120322073

2012-12-20

Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor

#512

20120309704

2012-12-06

COMPOSITIONS FOR TREATMENT OF CHEMORESISTANT AND/OR POTENTIALLY CHEMORESISTANT LEUKAEMIAS

#513

20120309029

2012-12-06

Methods for diagnosis, prognosis and methods of treatment

#514

20120294801

2012-11-22

Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses

#515

20120294800

2012-11-22

TARGETING TUMOR CELLS WITH CHEMOTHERAPEUTIC AGENTS CONJUGATED TO MATRIPTASE ANTIBODIES

#516

20120283124

2012-11-08

Cell Surface Marker Expression in Hematopoietic Stem Cells and Progenitors for the Diagnosis, Prognosis, and Treatment of Myelodysplastic Syndromes

#517

20120282183

2012-11-08

Inhibition of the interaction between 5T4 oncofoetal glycoproteins and CXC chemokine receptors as a method of identifying chemotaxis inhibitors

#518

20120277109

2012-11-01

PROXIMITY-MEDIATED ASSAYS FOR DETECTING ONCOGENIC FUSION PROTEINS

#519

20120264152

2012-10-18

Diagnostic and prognostic assays based on circulating tyrosine kinase activity

#520

20120264151

2012-10-18

System and method for diagnosing lymphoma in cats

#521

20120251557

2012-10-04

GalNAc-SPECIFIC BINDING MOLECULES AND USES THEREOF

#522

20120237488

2012-09-20

LSC AND HSC SIGNATURES FOR PREDICTING SURVIVAL OF PATIENTS HAVING HEMATOLOGICAL CANCER

#523

20120225426

2012-09-06

BAALC EXPRESSION AS A DIAGNOSTIC MARKER FOR ACUTE LEUKEMIA

#524

20120225059

2012-09-06

Method for inducing cell death in acute lymphoblastic leukemic system cells

#525

20120214710

2012-08-23

METHOD OF PREDICTING RESPONSE TO THALIDOMIDE IN MULTIPLE MYELOMA PATIENTS

#526

20120201837

2012-08-09

Use of eIF3m for the diagnosis and treatment of cancer

#527

20120184494

2012-07-19

MULTIPLE MYELOMA PROGNOSIS AND TREATMENT

#528

20120178180

2012-07-12

METHODS FOR THE IDENTIFICATION OF ZAP-70 INTERACTING MOLECULES AND FOR THE PURIFICATION OF ZAP-70

#529

20120171670

2012-07-05

BCR-ABL1 splice variants and uses thereof

#530

20120157331

2012-06-21

Screening methods for detection of susceptibility to leukemia and lymphomas

#531

20120156218

2012-06-21

NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER

#532

20120145891

2012-06-14

Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies

#533

20120135424

2012-05-31

MER DIAGNOSTIC AND THERAPEUTIC AGENTS

#534

20120135419

2012-05-31

Method of determination of diagnosis and prognosis in patients with B-cell chronic lymphocytic leukemia and oligonucleotides for use in this method

#535

20120135415

2012-05-31

DETECTING CANCER WITH ANTI-CXCL13 AND ANTI-CXCR5 ANTIBODIES

#536

20120134986

2012-05-31

Methods of Prognosis for Non-Hodgkin Lymphoma

#537

20120129167

2012-05-24

Truncated CD20 protein, deltaCD20

#538

20120128651

2012-05-24

ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) BIOMARKERS

#539

20120128586

2012-05-24

METHOD FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA

#540

20120121506

2012-05-17

Targeting of bone marrow neovasculature

#541

20120121504

2012-05-17

B cell surface reactive antibodies

#542

20120115134

2012-05-10

METHODS FOR DIAGNOSIS AND PROGNOSIS OF CANCER

#543

20120107821

2012-05-03

Methods for the diagnosis and prognosis of leukemia and other cancer types

#544

20120100131

2012-04-26

Method for treatment of blood tumor using anti-TIM-3 antibody

#545

20120095032

2012-04-19

METHODS FOR TREATING LEUKEMIA AND MYELODYSPLASTIC SYNDROME, AND METHODS FOR IDENTIFYING AGENTS FOR TREATING SAME

#546

20120094927

2012-04-19

Therapy for MLL-rearranged leukemia

#547

20120087918

2012-04-12

Methods and compositions for inhibiting the growth of hematopoietic malignant cells

#548

20120071629

2012-03-22

APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCER

#549

20120071418

2012-03-22

Inhibitors of human EZH2 and methods of use thereof

#550

20120070450

2012-03-22

LEUKEMIA STEM CELL MARKERS

#551

20120070448

2012-03-22

Antibody to human IL-3 receptor alpha chain

#552

20120066776

2012-03-15

Identification of a JAK2 mutation involved in vaquez polyglobulia

#553

20120058910

2012-03-08

Method for diagnosing acute lymphomic leukemia (ALL) using miR-125b

#554

20120053225

2012-03-01

AKT tyrosine 176 phosphorylation cancer biomarker

#555

20120052059

2012-03-01

REGULATORY B CELLS AND THEIR USE

#556

20120046451

2012-02-23

ANTI-lgSF4 ANTIBODY AND UTILIZATION OF THE SAME

#557

20120046194

2012-02-23

Method for diagnosing acute lymphomic leukemia (ALL) using miR-146a

#558

20120046193

2012-02-23

Method for diagnosing acute lymphomic leukemia (ALL) using miR-222

#559

20120046192

2012-02-23

Method for diagnosing acute lymphomic leukemia (ALL) using miR-221

#560

20120030780

2012-02-02

TARGETING OF SALL4 FOR THE TREATMENT AND DIAGNOSIS OF PROLIFERATIVE DISORDERS ASSOCIATED WITH MYELODYSPLASTIC SYNDROME (MDS)

#561

20120015906

2012-01-19

USES OF BORTEZOMIB IN PREDICTING SURVIVAL IN MULTIPLE MYELOMA PATIENTS

#562

20120015845

2012-01-19

MARKERS FOR THE DIAGNOSIS OF AML, B-ALL AND T-ALL

#563

20120003744

2012-01-05

DIAGNOSTIC METHODS

#564

20120003299

2012-01-05

Hsp9O-targeted anti-cancer chimeric peptide

#565

20110312968

2011-12-22

METHOD FOR OPTIMIZING THE TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH ABL TYROSINE KINASE INHIBITORS

#566

20110311445

2011-12-22

DIAGNOSIS AND TREATMENT OF MYELOID AND LYMPHOID CELL CANCERS

#567

20110307964

2011-12-15

Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof

#568

20110300128

2011-12-08

USE OF FOXP2 AS A MARKER FOR ABNORMAL LYMPHOCYTES AND AS A TARGET FOR THERAPY OF DISORDERS ASSOCIATED WITH ABNORMAL LYMPHOCYTES

#569

20110288102

2011-11-24

IL-8 biomarker for monitoring cancer treatment with certain ERK inhibitors

#570

20110269638

2011-11-03

Genes associated with post relapse survival and uses thereof

#571

20110269171

2011-11-03

METHODS AND MATERIALS FOR USING NKAP POLYPEPTIDE EXPRESSION LEVELS OR PATTERNS TO DETECT OR ASSESS CANCER

#572

20110269154

2011-11-03

Methods for diagnosis, prognosis and methods of treatment

#573

20110263523

2011-10-27

TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms

#574

20110262454

2011-10-27

NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER

#575

20110262425

2011-10-27

THERAPEUTIC AGENT FOR MLL LEUKEMIA AND MOZ LEUKEMIA OF WHICH MOLECULAR TARGET IS M-CSF RECEPTOR, AND USE THEREOF

#576

20110257366

2011-10-20

Method for screening candidate compounds for antitumor drug

#577

20110256055

2011-10-20

APPLICATION OF 99MTC PEPTIDE-BASED COMPOUND AS A BONE MARROW IMAGING AGENT

#578

20110251252

2011-10-13

BIOMARKERS FOR MDM2 INHIBITORS FOR USE IN TREATING DISEASE

#579

20110243934

2011-10-06

EPHA3 ANTIBODIES FOR THE TREATMENT OF MULTIPLE MYELOMA

#580

20110236915

2011-09-29

ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

#581

20110236387

2011-09-29

Polypeptides and antibodies derived from chronic lymphocytic Leukemia cells and uses thereof

#582

20110212022

2011-09-01

Antitumor antibodies, proteins, and uses thereof

#583

20110195022

2011-08-11

CD20 antibodies and uses thereof

#584

20110195021

2011-08-11

CD20 antibodies and uses thereof

#585

20110190220

2011-08-04

Use of Defensin Alpha 1 and/or Defensin Alpha 4, as a Marker for Predicting Treatment Response and/or a Relapse in a Patient Suffering form Chronic Myeloid Leukemia

#586

20110189202

2011-08-04

Compositions comprising soluble CD84 or anti-CD84 antibodies and methods for diagnosing and treating B-CLL

#587

20110189175

2011-08-04

Chronic lymphocytic leukemia prognosis and treatment

#588

20110177977

2011-07-21

Antibodies for detecting or monitoring a malignant plasma cell disease

#589

20110177535

2011-07-21

Method of detecting or monitoring a malignant plasma cell disease

#590

20110177088

2011-07-21

Method for treating and diagnosing hematologic malignancies

#591

20110177077

2011-07-21

PAX 5 monoclonal antibody

#592

20110172288

2011-07-14

Compositions and methods for the identification, assessment, prevention and therapy of thymic lymphoma or hamartomatous tumours

#593

20110171204

2011-07-14

Antibodies to NTB-A

#594

20110165164

2011-07-07

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS

#595

20110160160

2011-06-30

Methods for heat shock protein dependent cancer treatment

#596

20110159492

2011-06-30

Diffuse Large B-Cell Lymphoma Markers and Uses Therefore

#597

20110143367

2011-06-16

Antibodies against APRIL as biomarkers for early prognosis of lymphoma patients

#598

20110136224

2011-06-09

MDA-7 PROTEINS AND METHODS OF USE THEREOF

#599

20110135633

2011-06-09

Methods for treating chronic lymphocytic leukemia

#600

20110130343

2011-06-02

Immunity-inducing agent and method for detection of cancer